RxE2 Direct-to-Patient IP Dispensing for a Dose-Ranging Phase 1/2 Decentralized Clinical Trial

Case Studies

Introduction In an innovative approach to improve clinical trial outcomes, RxE2 pioneered the integration of pharmacy practices into clinical trial workflows. This case study examines our collaboration with a large Contract Research Organization (CRO) working on behalf of a mid-sized pharmaceutical company, facing the challenge of executing a cost-effective, direct-to-patient solution for a complex Phase…

Community Pharmacy Driven Recruitment in an Observational Vaccine Study

Case Studies

Introduction & Study Background The rapid enrollment of participants is a cornerstone of clinical trial success. A large biopharmaceutical company, faced with the imminent start of an observational vaccine study, sought innovative strategies to enhance patient recruitment efficiency. The company aimed to recruit and register a significant number of novel patients to the trial’s registry…

Enhancing Patient Recruitment through Community Pharmacies for a Phase 2 Neurological Study

Case Studies

Introduction A small biopharmaceutical company embarked on a Phase 2 study targeting a neurological disease related to mental health, necessitating the development of a pre-study registry to identify patients possessing a rare biomarker. Traditional recruitment methods proved inadequate, prompting the exploration of alternative strategies to augment the patient registry. Study Background & Challenges The study’s…

diversity

Case Study: Phase III clinical trial in the United States | 2022

Case Studies

Client A biopharmaceutical company sponsoring a Phase III clinical trial in the United States. Challenge The trial required the recruitment of patients with a neurological pain indication. The sponsor perceived a potential concern that patients had several alternative treatment options, including commercially available products, and therefore, may not be interested in a clinical study opportunity…